Ciencias de la Salud
Área
University Medical Center Utrecht
Utrecht, HolandaPublikationen in Zusammenarbeit mit Forschern von University Medical Center Utrecht (20)
2024
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14
2019
2018
-
Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones
Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 3039-3043
-
Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe
Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 2973-2980
2016
-
The global spread of HIV-1 subtype B epidemic
Infection, Genetics and Evolution, Vol. 46, pp. 169-179
2015
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
-
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe
Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1027-1032
2014
-
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study
BMC Nephrology, Vol. 15, Núm. 1
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2012
2011
-
European guidelines on the clinical management of HIV-1 tropism testing
The Lancet Infectious Diseases, Vol. 11, Núm. 5, pp. 394-407
-
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
AIDS Reviews, Vol. 13, Núm. 2, pp. 77-108
2009
-
Tracing the HIV-1 subtype B mobility in Europe: A phylogeographic approach
Retrovirology, Vol. 6
-
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal
Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151
2006
-
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
Journal of Acquired Immune Deficiency Syndromes, Vol. 41, Núm. 3, pp. 352-360
2005
-
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management
Journal of Infectious Diseases, Vol. 192, Núm. 6, pp. 958-966
2004
-
Updated European recommendations for the clinical use of HIV drug resistance testing
Antiviral Therapy, Vol. 9, Núm. 6, pp. 829-848
2002
-
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
Blood, Vol. 100, Núm. 12, pp. 3877-3886